Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rbv Treatment'

Rbv Treatment published presentations and documents on DocSlides.

MK3 MK3 + RBV

MK3 MK3 + RBV

  • min-jolicoeur
  • 10 Slides

Randomisation. Open-label. W8. * Liver biopsy or ...

SOF + EBR + GZR + RBV

SOF + EBR + GZR + RBV

  • test
  • 4 Slides

N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...

PEG alfa-2a RBV versus

PEG alfa-2a RBV versus

  • alexa-scheidler
  • 0 Slides

. PEG alfa-. 2a . versus. INF RBV . APRICOT S...

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

  • UnicornLove
  • 7 Slides

C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...

3 D (Paritaprevir

3 D (Paritaprevir

  • myesha-ticknor
  • 13 Slides

-Ritonavir. -Ombitasvir . + Dasabuvir) . + RBV in...

C-SCAPE

C-SCAPE

  • pasty-toler
  • 14 Slides

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

SIRIUS

SIRIUS

  • tawny-fly
  • 10 Slides

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

TURQUOISE-I

TURQUOISE-I

  • natalia-silvester
  • 5 Slides

OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...

GZR + EBR

GZR + EBR

  • celsa-spraggs
  • 5 Slides

C-WORTHY Study Part C: . grazoprevir. . + . elba...

Direct Acting Antivirals: What are they? What is their pl

Direct Acting Antivirals: What are they? What is their pl

  • tawny-fly
  • 28 Slides

Mark Sulkowski, MD. Associate Professor of Medici...

Étude PEARL III : ABT-450/r/267 + ABT-333 ± RBV

Étude PEARL III : ABT-450/r/267 + ABT-333 ± RBV

  • tatiana-dople
  • 4 Slides

dans les génotypes 1b naïfs de traitement . (1)...

David Fletcher, MD

David Fletcher, MD

  • tatiana-dople
  • 24 Slides

Department of Medicine. University of Toronto. Co...

C-SCAPE

C-SCAPE

  • tawny-fly
  • 10 Slides

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

TURQUOISE-I

TURQUOISE-I

  • marina-yarberry
  • 11 Slides

OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...

C-WORTHY Study Part

C-WORTHY Study Part

  • karlyn-bohler
  • 12 Slides

D : . grazoprevir. . + . elbasvir. + RBV in ge...

PEG alfa-2a +

PEG alfa-2a +

  • tawny-fly
  • 8 Slides

RBV . versus. . PEG alfa-. 2a . versus. INF + R...

Ombitasvir-

Ombitasvir-

  • kittie-lecroy
  • 9 Slides

Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...

SAPPHIRE-I

SAPPHIRE-I

  • ellena-manuel
  • 8 Slides

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

Forns

Forns

  • ellena-manuel
  • 6 Slides

X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...

COSMOS

COSMOS

  • sherrill-nordquist
  • 8 Slides

SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...

C-WORTHY/B

C-WORTHY/B

  • stefany-barnette
  • 8 Slides

Randomisation*. Open-label. >. 18 years. HCV ...

Peginterferon alfa-2a +

Peginterferon alfa-2a +

  • stefany-barnette
  • 8 Slides

RBV . versus. Interferon alfa. -. 2a + RBV . ACT...

OBV/PTV/r DSV Open label

OBV/PTV/r DSV Open label

  • kittie-lecroy
  • 0 Slides

≥ 18 years. Chronic HCV infection. Genotype 1. ...

M.W. Fried , 1 M. Buti,

M.W. Fried , 1 M. Buti,

  • iamamercy
  • 18 Slides

2. G.J. Dore,. 3. P. Ferenci,. 4. . I. Jacobson...

522432468WPbVZOeORbVcPSUZbVSTZZeWUTbVaTbVSgcbeeWbVaSWRbVObVbbVgTTWRc

522432468WPbVZOeORbVcPSUZbVSTZZeWUTbVaTbVSgcbeeWbVaSWRbVObVbbVgTTWRc

  • daisy
  • 7 Slides

B7AB8DW10--62712/0216U28411204- f-25189455DVReWbVT...

CURRY

CURRY

  • faustina-dinatale
  • 13 Slides

Design. Open-label. CURRY . Study. : SOF + RBV fo...

The Resource Based View of the Firm (RBV)

The Resource Based View of the Firm (RBV)

  • celsa-spraggs
  • 36 Slides

B290. The object of strategic analysis…. Explai...

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

  • conchita-marotz
  • 10 Slides

SAPPHIRE-I. Phase 3. . Treatment. . Naïve. Fel...

Simeprevir in

Simeprevir in

  • ellena-manuel
  • 14 Slides

Genotype . 1 . (. Viral . Relapsers. ). PROMISE ....

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

  • lois-ondreau
  • 21 Slides

3. Rd. International . HIV/Hepatitis . Coinfecti...

Ombitasvir-Paritaprevir

Ombitasvir-Paritaprevir

  • tatiana-dople
  • 9 Slides

-. Ritonavir . and Dasabuvir . + RBV in . GT1. SA...

MK3 + RBV

MK3 + RBV

  • jane-oiler
  • 5 Slides

N = 45. N = 49. W24. W16. MK3. > . 18 years. H...

Placebo + PR

Placebo + PR

  • aaron
  • 6 Slides

W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...

ALLY-1

ALLY-1

  • stefany-barnette
  • 6 Slides

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

Not randomised Open-label

Not randomised Open-label

  • cheryl-pisano
  • 0 Slides

18-70 years. HCV genotype 1 or 3. Naïve or failu...

The Resource Based View of the Firm (RBV)

The Resource Based View of the Firm (RBV)

  • alida-meadow
  • 0 Slides

B290. The object of strategic analysis…. Explai...

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

  • alida-meadow
  • 0 Slides

SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...

HIV Pipeline Doravirine 2

HIV Pipeline Doravirine 2

  • giovanna-bartolotta
  • 0 Slides

(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...

HIV Pipeline Cabotegravir-LA

HIV Pipeline Cabotegravir-LA

  • liane-varnes
  • 0 Slides

(GSK-744; CAB). For . PrEP. INI. ViiV. Topical mi...

SOF/VEL 400/100 mg qd N = 75

SOF/VEL 400/100 mg qd N = 75

  • danika-pritchard
  • 0 Slides

W24. SOF/VEL. >. 18 years. Chronic HCV infect...

Copyright © 2024 DocSlides. All Rights Reserved